There is a possibility that, in addition to fibrocyte-like cells, tumour-infiltrated macrophages may also contribute on angiogenesis in our model, as the number of CD45+/F4/80+ macrophages was slightly increased with bevacizumab treatment (Fig. 5c). Here, PTPRC is linked to neoplasm.